In the US electrophysiology devices market, the companies with the highest market share by revenue are Johnson & Johnson and Boston Scientific, with Johnson & Johnson in the lead. Although Boston Scientific is currently behind Johnson & Johnson, its FARAWAVE pulsed field ablation catheter has quickly gained market share and become the highest-revenue product line in the market.
The market has seen fluctuations historically; however, no other product has been able to gain as much market share as FARAWAVE, according to leading data and analytics company GlobalData’s US Healthcare Facility Invoicing Database. Johnson & Johnson has held the majority market share for over a decade. Since the first quarter of 2024, the company has seen a decline in market share, coinciding with the rise in market share of Boston Scientific. Since FARAWAVE was approved in 2024, it has reached over double the market share that the next largest product has.
Go deeper with GlobalData
Access deeper industry intelligence
Experience unmatched clarity with a single platform that combines unique data, AI, and human expertise.
GlobalData is seeing an increase in Medtronic’s market share, coming close to Abbott. If Medtronic can maintain this increase and overtake Abbott in market share, it can secure the third-highest market share. The electrophysiology device market has constantly changed over time, but seems to have steadied recently.
GlobalData will continue to monitor the companies in this space. In the coming months, Boston Scientific may keep climbing to overtake Johnson & Johnson, or could remain just behind. Across the electrophysiology devices market, Boston Scientific and Johnson & Johnson have similar average selling prices. In order to remain competitive, both companies may have to find ways other than pricing to set themselves apart.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalData
